Amgen Inc. (AMGN) Stock

NASDAQ: AMGNBiotechnology company that develops and manufactures human therapeutics, focusing on areas such as oncology, cardiovascular, and inflammation.

Amgen stock price chart

AMGN interactive chart →

AMGN stock quote & key statistics

Amgen earnings per share

Income →

Earnings per share

Amgen revenue & net income

Income →

RevenueNet income

Amgen annual financials

Income statement →

Amgen Inc. revenue, net income and EPS by fiscal year
Fiscal year	Revenue	Net income	EPS
FY2025	$36.74B	$7.71B	$21.85
FY2024	$33.42B	$4.09B	$19.82
FY2023	$28.19B	$6.72B	$18.65
FY2022	$26.32B	$6.55B	$17.69
FY2021	$25.98B	$5.89B	$17.11

Fiscal year ending December 31. Source: company filings via EODHD.

About Amgen Inc.

Amgen Inc. is a prominent global biotechnology company specializing in the discovery, development, manufacturing, and distribution of human therapeutics. The company focuses on a wide spectrum of therapeutic areas including inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience.

Amgen's diverse product portfolio includes Enbrel, utilized for treating conditions like plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis. Neulasta reduces infection risks in cancer patients with low white blood cell counts. Prolia addresses osteoporosis in postmenopausal women, while Xgeva prevents skeletal-related events. Otezla treats adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers related to Behçet's disease. Additionally, Amgen offers Aranesp for anemia, KYPROLIS for relapsed or refractory multiple myeloma, and Repatha to lower risks of myocardial infarction, stroke, and coronary revascularization.

Amgen distributes its extensive product range to healthcare providers such as physicians, clinics, dialysis centers, hospitals, and pharmacies through pharmaceutical wholesale distributors and direct-to-consumer channels. The company has collaborative agreements with major entities including Novartis Pharma AG, UCB, Bayer HealthCare LLC, and Eli Lilly and Company, enhancing its global reach and impact in the biopharmaceutical industry.

Established in 1980 and headquartered in Thousand Oaks, California, Amgen continues to innovate through partnerships and research collaborations, exemplifying its commitment to advancing medical science and improving patient outcomes worldwide.

Amgen stock FAQ

What is the Amgen stock ticker symbol?

Amgen Inc. trades on the NASDAQ under the ticker symbol AMGN.

What sector and industry is Amgen in?

Amgen Inc. is classified in the Healthcare sector, Drug Manufacturers - General industry.

How many employees does Amgen have?

Amgen Inc. has about 31,500 full-time employees.

What were Amgen's revenue and earnings last fiscal year?

Amgen reported revenue of $36.74B and net income of $7.71B in fiscal 2025, with earnings per share of $21.85. Revenue grew 9.9% from the prior year.

Is Amgen in the Dow Jones Industrial Average?

Yes. Amgen Inc. (AMGN) is one of the 30 companies in the Dow Jones Industrial Average.

Is Amgen in the Nasdaq-100?

Yes. Amgen Inc. (AMGN) is a component of the Nasdaq-100 index, which tracks the largest non-financial companies listed on the Nasdaq Stock Market.

Is Amgen in the S&P 500?

Yes. Amgen Inc. (AMGN) is a component of the S&P 500, the index of 500 leading U.S. companies widely used as a benchmark for the U.S. stock market.

Is Amgen in the Russell 1000?

Yes. Amgen Inc. (AMGN) is a component of the Russell 1000, which tracks roughly the 1,000 largest U.S. companies.

When did Amgen go public?

Amgen stock began trading on June 17, 1983.